A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk.
Pharmaceutical Technology spoke with Richard Denk, senior consultant aseptic processing and containment, SKAN AG, about the risks of contamination in biopharmaceutical manufacturing and how this risk can be mitigated.
Read this article in Pharmaceutical Technology Biologics and Sterile Drug Manufacturing May 2020 eBook.
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2020
May 2020
Pages: 38–42
When referring to this article, please cite it as S. Haigney, “Considerations in Contamination Control," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.